{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T02:31:08Z","timestamp":1778293868797,"version":"3.51.4"},"reference-count":78,"publisher":"Wiley","issue":"5","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd002852","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T03:38:44Z","timestamp":1069385924000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Haloperidol for agitation in dementia"],"prefix":"10.1002","volume":"2012","author":[{"given":"Edmund","family":"Lonergan","sequence":"first","affiliation":[{"name":"4 Captain Drive Apt 215 Emeryville CA USA 94608"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay","family":"Luxenberg","sequence":"additional","affiliation":[{"name":"Jewish Home 302 Silver Ave San Francisco California USA 94112"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John M","family":"Colford","sequence":"additional","affiliation":[{"name":"University of California at Berkeley; Epidemiology; 140 Warren Hall School of Public Health Berkeley CA USA CA 94720"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Birks","sequence":"additional","affiliation":[{"name":"University of Oxford; Centre for Statistics in Medicine; Wolfson College Linton Road Oxford UK OX2 6UD"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,4,22]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD002852-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s002130050064","article-title":"Double blind study of tiapride versus haloperidol and placebo in agitation and aggressiveness in elderly patients with cognitive impairment","volume":"148","author":"Allain","year":"2000","journal-title":"Psychopharmacology"},{"key":"10.1002\/14651858.CD002852-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1176\/jnp.9.4.591","article-title":"Pilot study of haloperidol, fluoxetine, and placebo for agitation in Alzheimer's disease","volume":"9","author":"Auchus","year":"1997","journal-title":"Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"10.1002\/14651858.CD002852-BIB0006|cit3","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1176\/ajp.156.12.2019-a","article-title":"Haloperidol and Alzheimer's disease [Reply]","volume":"156","author":"Devanand","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0003|cit4","unstructured":"Devanand DP Marder K Michaels K Sackeim HA Bell K Sullivan M Cooper T Mayeux R A randomized, placebo-controlled, dose-comparison trial of haloperidol treatment for the behavioral complications of Alzheimer's disease Proceedings of the 36th Annual Meeting of the American College of Neuropsychopharmacology; 1997 December 8-12, Waikoloa, Hawai, USA 1997 1997"},{"key":"10.1002\/14651858.CD002852-BIB0004|cit5","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1176\/ajp.155.11.1512","article-title":"A randomized, placebo-controlled dose-comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease","volume":"155","author":"Devanand","year":"1998","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0005|cit6","unstructured":"Devanand DP Rodriguez JF Marder K Bell K Sackeim HA Stern Y Mayeux R Low dose haloperidol treatment of behavioural complications in Alzheimer's disease Proceedings of the 8th Congress of the International Psychogeriatric Association; 1997 August 17-22, Jerusalem, Israel 1997 1997 83"},{"key":"10.1002\/14651858.CD002852-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00019442-200303000-00009","article-title":"Usefulness of plasma haloperidol levels for monitoring clinical efficacy and side effects in Alzheimer patients with psychosis and behavioral dyscontrol","volume":"11","author":"Pelton","year":"2003","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"DeDeyn","year":"1999","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002852-BIB0009|cit9","unstructured":"Teri L Logsdon RG Peskind E Raskind M Weiner MF Tractenberg RE Treatment of agitation in alzheimer's disease a randomized placebo controlled clinical trial Proceedings of the 6th International Stockholm\/Springfield Symposium on Advances in Alzheimer Therapy; 2000 April 5-8, Stockholm, Sweden 2000 2000 153"},{"issue":"9","key":"10.1002\/14651858.CD002852-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1212\/WNL.55.9.1271","article-title":"Treatment of agitation in AD. A randomized placebo-controlled clinical trial","volume":"55","author":"Teri","year":"2000","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002852-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/026988119901300207","article-title":"A comparison of the effects of olanzapine, haloperidol, and placebo on cognitive and psychomotor function in healthy elderly volunteers","volume":"13","author":"Beuzen","year":"1999","journal-title":"Journal of Psychopharmacology"},{"key":"10.1002\/14651858.CD002852-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/gps.930070407","article-title":"A behavioral microanalysis of the effects of haloperidol and oxazepam on psychogeriatric inpatients","volume":"7","author":"Burgio","year":"1992","journal-title":"Journal of Geriatric Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002852-BIB0013|cit13","first-page":"263","article-title":"A double-blind trial for agitation in a nursing home population with Alzheimer's disease","volume":"4","author":"Cantillon","year":"1996","journal-title":"American Journal of Geriatrics"},{"key":"10.1002\/14651858.CD002852-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/00004850-199300820-00004","article-title":"Aggression in the demented patient: a double-blind study of loxapine versus haloperidol","volume":"8","author":"Carlyle","year":"1993","journal-title":"International Clinical Psychopharmacology"},{"issue":"12","key":"10.1002\/14651858.CD002852-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1002\/gps.504","article-title":"A double-blind randomised comparison of risperidone and haloperidol in the treatment of behavioural and psychological symptoms in Chinese dementia patients","volume":"16","author":"Chan","year":"2001","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002852-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1532-5415.1998.tb01081.x","article-title":"Alprazolam as an alternative to low-dose haloperidol in older, cognitively impaired nursing facility patients","volume":"46","author":"Christensen","year":"1998","journal-title":"Journal of the American Geriatrics Society"},{"issue":"12","key":"10.1002\/14651858.CD002852-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1176\/ajp.147.12.1640","article-title":"Pharmacologic treatment of noncognitive behavioral disturbances in elderly demented patients","volume":"147","author":"Coccaro","year":"1990","journal-title":"American Journal of Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD002852-BIB0018|cit18","first-page":"411","article-title":"Double-blind study of thioridazine and haloperidol in geriatric patients with a psychosis associated with organic brain syndrome","volume":"40","author":"Cowley","year":"1979","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/archneur.1989.00520440036018","article-title":"A pilot study of haloperidol treatment of psychosis and behavioral disturbances in Alzheimer's disease","volume":"46","author":"Devanand","year":"1989","journal-title":"Archives of Neurology"},{"issue":"2","key":"10.1002\/14651858.CD002852-BIB0020|cit20","first-page":"124","article-title":"Haloperidol concentrations in patients with Alzheimer's dementia","volume":"2","author":"Dysken","year":"1994","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0021|cit21","unstructured":"Evans M Multi-centre double blind randomized parallel group comparison of seroquel and haloperidol in the treatment of elderly patients presenting with dementia, psychosis NRR Project NO262026571"},{"issue":"5","key":"10.1002\/14651858.CD002852-BIB0022|cit22","first-page":"285","article-title":"Zuclopenthixol and haloperidol\/levomepromazine in the treatment of elderly patients with symptoms of aggressiveness and agitation: a double-blind, multi-centre study","volume":"5","author":"Fuglum","year":"1989","journal-title":"Pharmacotherapeutica"},{"issue":"3","key":"10.1002\/14651858.CD002852-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3109\/08039489009096564","article-title":"Zuclopenthixol or haloperidol\/levopromazine in the elderly. A controlled multicenter double-blind study","volume":"44","author":"Fuglum","year":"1990","journal-title":"Nordisk Psykiatrisk Tidskrift"},{"key":"10.1002\/14651858.CD002852-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0167-4943(01)00135-2","article-title":"Sertraline Versus Small Doses of Haloperidol in the Treatment of Agitated Behavior in Patients With Dementia","volume":"7","author":"Gaber","year":"2001","journal-title":"Archives of Gerontology and Geriatrics"},{"key":"10.1002\/14651858.CD002852-BIB0025|cit25","first-page":"46","article-title":"A double-blind comparison of the effects of haloperidol and cis(Z)-clopenthixol in senile dementia","volume":"(Suppl) 294","author":"Gotestam","year":"1981","journal-title":"Acta Psychiatrica Scandinavia"},{"issue":"6","key":"10.1002\/14651858.CD002852-BIB0026|cit26","first-page":"469","article-title":"A controlled clinical trial of Buronil versus haloperidol for agitation in elderly patients","volume":"28","author":"Harnryd","year":"1974","journal-title":"Nordisk Psykiatrisk Tidskrift"},{"issue":"3","key":"10.1002\/14651858.CD002852-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"439","DOI":"10.4088\/JCP.v68n0314","article-title":"Antiaggressive effect of cyproterone versus haloperidol in Alzheimer's disease: a randomized double-blind pilot study","volume":"68","author":"Huertas","year":"2007","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0028|cit28","first-page":"354","article-title":"Effect of carbamazepine on agitation in Alzheimer's inpatients refractory to neuroleptics","volume":"56","author":"Lemke","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD002852-BIB0029|cit29","first-page":"234","article-title":"Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol","volume":"48","author":"Lovett","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002852-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/00004714-198204000-00008","article-title":"Loxapine in psychogeriatrics: a placebo- and standard-controlled clinical investigation","volume":"2","author":"Petrie","year":"1982","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"1","key":"10.1002\/14651858.CD002852-BIB0031|cit31","first-page":"17","article-title":"Double-blind comparison of haloperidol and thioridazine in geriatric outpatients","volume":"40","author":"Rosen","year":"1979","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002852-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1017\/S1461145705006036","article-title":"Treatment of behavioural, cognitive and circadian rest-activity cycle disturbances in Alzheimer's disease: haloperidol vs. quetiapine","volume":"9","author":"Savaskan","year":"2006","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD002852-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/S0033-3182(74)71262-2","article-title":"Haloperidol versus thioridazine for the treatment of psychogeriatric patients: a double-blind clinical trial","volume":"15","author":"Smith","year":"1975","journal-title":"Psychosomatics"},{"issue":"6","key":"10.1002\/14651858.CD002852-BIB0034|cit34","first-page":"310","article-title":"Haloperidol versus thioridazine in the treatment of behavioral symptoms in senile dementia of the Alzheimer's type: preliminary findings","volume":"47","author":"Steele","year":"1986","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1176\/ajp.120.12.1190","article-title":"Haloperidol in the psychiatric disorders of old age","volume":"120","author":"Sugarman","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"7","key":"10.1002\/14651858.CD002852-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/gps.1542","article-title":"Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia","volume":"21","author":"Suh","year":"2006","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002852-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/gps.1693","article-title":"Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia","volume":"22","author":"Suh","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD002852-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00019442-200409000-00009","article-title":"A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances","volume":"12","author":"Suh","year":"2004","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD002852-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00019442-199705010-00008","article-title":"A double-blind comparison of trazodone and haloperidol for treatment of agitation in patients with dementia","volume":"5","author":"Sultzer","year":"1997","journal-title":"Journal of Geriatric Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD002852-BIB0040|cit40","first-page":"156","article-title":"A randomized double-blind trial of haloperidol and risperidone for behavioral and psychological symptoms of dementia","volume":"37","author":"Sun","year":"2004","journal-title":"Chinese Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD002852-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/01.JGP.0000196628.12010.35","article-title":"Quetiapine treatment of psychosis associated with dementia: a double-blind, randomized, placebo-controlled clinical trial","volume":"14","author":"Tariot","year":"2006","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1532-5415.1991.tb04048.x","article-title":"Pharmacololgical treatment of agitation in a nursing home","volume":"39","author":"Billig","year":"1991","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD002852-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002852-BIB0044|cit44","first-page":"230","article-title":"The extrapyramidal symptom rating scale.","volume":"7","author":"Chouinard","year":"1980","journal-title":"Can J Neurol Sci"},{"key":"10.1002\/14651858.CD002852-BIB0045|cit45","volume-title":"Cochrane Reviewer's Handbook","author":"Clarke","year":"1999"},{"key":"10.1002\/14651858.CD002852-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1017\/S1041610289000165","article-title":"An observational study of agitation in agitated nursing home residents","volume":"1","author":"Cohen-Mansfield","year":"1989","journal-title":"International Psychogeriatrics"},{"key":"10.1002\/14651858.CD002852-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"M77","DOI":"10.1093\/geronj\/44.3.M77","article-title":"A description of agitation in a nursing home","volume":"44","author":"Cohen-Mansfield","year":"1989","journal-title":"Journal of Gerontology"},{"key":"10.1002\/14651858.CD002852-BIB0048|cit48","doi-asserted-by":"crossref","unstructured":"Cohen-Mansfield J Conceptualization of agitation: results based on the Cohen-Mansfield Agitation Inventory and the Agitation Behavior Mapping Instrument 1996 309 15","DOI":"10.1017\/S1041610297003530"},{"key":"10.1002\/14651858.CD002852-BIB0049|cit49","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD002852-BIB0050|cit50","first-page":"S81","article-title":"Haloperidol treatment of behavioral disturbances in Alzheimer patients","volume":"15 (Suppl 1)","author":"Dysken","year":"1994","journal-title":"Neurobiology of Aging"},{"key":"10.1002\/14651858.CD002852-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/archpsyc.1978.01770310043002","article-title":"A diagnostic interview: the Schedule for Affective Disorders and Schizophrenia","volume":"35","author":"Endicott","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini Mental State. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD002852-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1176\/ajp.156.12.2019","article-title":"Haloperidol and Alzheimer's disease [letter]","volume":"156","author":"Frisoni","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0054|cit54","volume-title":"ECDEU assessment manual for psychopharmacology, revised","volume":"76-338","author":"Guy","year":"1976"},{"key":"10.1002\/14651858.CD002852-BIB0055|cit55","first-page":"733","article-title":"Multidimensional observation scale for elderly subjects (MOSES)","volume":"24","author":"Helms","year":"1989","journal-title":"Psychopharmacol Bull"},{"key":"10.1002\/14651858.CD002852-BIB0056|cit56","volume-title":"The ICD-10 Classification of Mental and Behavioral Disorders: Diagnostic Criteria for Research","author":"World Health Organization","year":"1993"},{"key":"10.1002\/14651858.CD002852-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1111\/j.1532-5415.2000.tb03899.x","article-title":"Why systematic reviews?","volume":"48","author":"Jacobs","year":"2000","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD002852-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"550","DOI":"10.4088\/JCP.v59n1010","article-title":"Efficacy and safety of neuroleptics in behavioral disorders associated with dementia","volume":"59","author":"Lanctot","year":"1998","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0059|cit59","first-page":"85","article-title":"The UKU (Udvalg for Kliniske Undersogelser) side effects rating scale","volume":"76","author":"Lingjaerd","year":"1987","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD002852-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1532-5415.1999.tb07439.x","article-title":"Assessment of agitation in Alzheimer's disease: the Agitated Behavior in Dementia Scale","volume":"47","author":"Logsdon","year":"1999","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1002\/14651858.CD002852-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical Diagnosis of Alzheimer's Disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease","volume":"4","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1002\/14651858.CD002852-BIB0062|cit62","article-title":"Cochrane Collaboration Handbook","volume-title":"Cochrane Collaboration Handbook (updated 9 December 1996)","author":"Mulrow","year":"1997"},{"key":"10.1002\/14651858.CD002852-BIB0063|cit63","first-page":"218","article-title":"Clinical global impressions","volume-title":"ECDEU Assessment for Psychopharmacology","author":"National Institute of Mental Health","year":"1976"},{"key":"10.1002\/14651858.CD002852-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"key":"10.1002\/14651858.CD002852-BIB0065|cit65","first-page":"653","article-title":"Functional assessment staging","volume":"24","author":"Reisberg","year":"1988","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD002852-BIB0066|cit66","first-page":"95","article-title":"Stage specific incidence of potentially remediable behvioral symptoms in aging and Alzheimer's disease: as study of 120 patients using the BEHAVE-AD","volume":"54","author":"Reisberg","year":"1989","journal-title":"Bulletin Neuroscience"},{"key":"10.1002\/14651858.CD002852-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1532-5415.1990.tb02407.x","article-title":"A Meta-analysis of controlled trials of neuroleptic treatment in dementia","volume":"38","author":"Schneider","year":"1990","journal-title":"Journal of the American Geriatrics Society"},{"issue":"Suppl 8","key":"10.1002\/14651858.CD002852-BIB0068|cit68","first-page":"375","article-title":"Meta-analysis of controlled pharmacologic trials","volume":"3","author":"Schneider","year":"1996","journal-title":"International Psychgeriatrics"},{"key":"10.1002\/14651858.CD002852-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/00002093-199700112-00004","article-title":"Validity and reliability of the Alzheimer's disease cooperative study Clinical Global Impression of change","volume":"11","author":"Schneider","year":"1997","journal-title":"Alzheimer Disease and Associated Disorders"},{"key":"10.1002\/14651858.CD002852-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/jama.1994.03520020051014","article-title":"Assessing the quality of randomization from the reports of controlled trials published in obstetrics and gynecology journals","volume":"272","author":"Schulz","year":"1994","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002852-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF00496058","article-title":"A rating scale for tardive dyskinesia","volume":"64","author":"Simpson","year":"1979","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1002\/14651858.CD002852-BIB0072|cit72","unstructured":"Stehli A Does haloperidol reduce psychomotor agitation in dementia patients? A meta-analysis Unpublished thesis in support of the Masters degree, University of California at Berkeley 2000"},{"key":"10.1002\/14651858.CD002852-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00019442-200409000-00009","article-title":"A randomized, double-blind, crossover comparison of risperidone and haloperidol in Korean dementia patients with behavioral disturbances","volume":"12","author":"Suh","year":"2004","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD002852-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1037\/0882-7974.7.4.622","article-title":"Assessment of behavioral problems in dementia: the revised memory and behavior problems checklist","volume":"7","author":"Teri","year":"1992","journal-title":"Psychology and Aging"},{"key":"10.1002\/14651858.CD002852-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/geront\/31.1.76","article-title":"The screen for caregiver burden","volume":"31","author":"Vitaliano","year":"1991","journal-title":"Gerontologist"},{"key":"10.1002\/14651858.CD002852-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/089198870201500208","article-title":"No long-term effect of behavioral treatment on psychotropic drug use for agitation in Alzheimer's disease patients","volume":"15","author":"Weiner","year":"2002","journal-title":"Journal of Geriatric Psychiatry and Neurology"},{"key":"10.1002\/14651858.CD002852-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/0010-440X(80)90018-8","article-title":"Prevalence of tardive dyskinesia in an outpatient population","volume":"21","author":"Wocjik","year":"1980","journal-title":"Comprehensive Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD002852-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002852","article-title":"Haloperidol for agitation in dementia","author":"Lonergan","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD002852\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T07:02:47Z","timestamp":1739948567000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD002852"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2002,4,22]]},"references-count":78,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2012,5]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002852","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,4,22]]}}}